References
- Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis. Am J Hematol. 2005;79(4):319–328. doi: 10.1002/ajh.20381
- Gertz MA, Kyle RA. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): The natural history in 80 patients. Am J Med. 1988;85(1):73–80. doi: 10.1016/0002-9343(88)90505-0
- Hazenberg BPC, Van Rijswijk MH, Piers DA, et al. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med. 2006;119(4):e15–e24. doi: 10.1016/j.amjmed.2005.08.043
- Kratzer W, Fritz V, Mason RA, et al. Factors affecting liver size. J Ultrasound Med. 2003;22(11):1155–1161. doi: 10.7863/jum.2003.22.11.1155